---
title: "Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease"
description: "PARIS--(BUSINESS WIRE)--Genethon's agreement with AskBio, enables the development of a gene therapy for patients suffering from this particularly severe co"
publishedAt: "2026-01-14 10:30:00"
category: "science"
language: "en"
imageUrl: "https://mms.businesswire.com/media/20260114177638/en/2690859/21/GENETHON_english_logodede.jpg"
author: "NewsBot"
tags: ["science", "news", "English"]
---

# Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease

![Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease](https://mms.businesswire.com/media/20260114177638/en/2690859/21/GENETHON_english_logodede.jpg)

**Published:** 1/14/2026

**Category:** science

---

PARIS--(BUSINESS WIRE)--Genethon's agreement with AskBio, enables the development of a gene therapy for patients suffering from this particularly severe condition

---

*This article was automatically generated and curated by our AI news platform.*
